XML 24 R54.htm IDEA: XBRL DOCUMENT v3.20.1
CAPITAL STRUCTURE (Details Narrative) - USD ($)
1 Months Ended 12 Months Ended
Feb. 05, 2019
Jan. 07, 2019
Jun. 20, 2019
Feb. 18, 2019
Nov. 30, 2018
Sep. 29, 2018
Jun. 18, 2018
Dec. 19, 2017
May 25, 2017
Dec. 31, 2019
Dec. 31, 2018
Dec. 31, 2017
Common stock, shares, outstanding                   12,860,059 13,685,067  
Common stock, shares issued                   13,225,387 13,878,757  
Common stock shares authorized                   300,000,000 300,000,000 300,000,000
Preferred stock shares authorized                   100,000,000 100,000,000 100,000,000
Cancellation of pre-delivery shares issued in connection with convertible debentures 108,417 465,325                  
Common stock value                   $ 13,225 $ 13,879  
Related party accrual for repurchase of shares of common stock                   48,683  
Gain on sale of Amplerissimo                   146,647  
Revenue                   39,676,385 37,083,882  
SkyPharm [Member]                        
Purchase price           $ 2,528            
Ownership percentage           100.00%            
Percentage of ownership interest transferred to company by amplerissimo           22.00%            
Revenue                   1,057,916 $ 1,247,208  
Amplerissimo Ltd [Member] | Fiscal 2018 [Member]                        
Revenue                   $ 7,639,022    
Stock Purchase Agreement [Member] | Institutional Noteholder [Member]                        
Common stock, shares purchased 193,408                    
Cancellation and transfer of shares                   193,408    
Payment made against shares purchased                   $ 580,224    
Common stock, purchase price $ 3.00                      
Aggregate common stock value $ 580,224                      
Stock Purchase Agreement [Member] | Institutional Noteholder One [Member]                        
Common stock, shares purchased     83,341        
Cancellation and transfer of shares                   26,221    
Treasury stock, shares transferred                   57,120    
Payment made against shares purchased                   $ 250,023    
Common stock, purchase price     $ 3.00                
Aggregate common stock value     $ 250,023                
Stock Purchase Agreement [Member] | Former Officer and Director [Member]                        
Repurchased of common shares     114,518                  
Consideration paid against shares     $ 15,000             15,000    
Consulting agreement [Member]                        
Common stock, shares issued                 20,000      
Commencing agreement date                 May 25, 2017      
Consulting agreement period                 20 months      
Common stock value                 $ 154,000      
Price per share                 $ 7.70      
Consultant charges                 $ 56,138      
Consulting expense yet to be recognized                 $ 92,299      
Tranche [Member]                        
Purchase of treasury stock from officer                       $ 33,073
Related party accrual for repurchase of shares of common stock                       61,422
Tranche 1 [Member]                        
Purchase of treasury stock from officer                     $ 63,446  
Gain/Loss of change in foreign currency                     2,024  
Tranche 2 [Member]                        
Purchase of treasury stock from officer                   69,178  
Gain/Loss of change in foreign currency                   $ 434  
Share purchase agreement [Member] | Amplerissimo Ltd [Member] | Fiscal 2018 [Member]                        
Purchase price                   5,811    
Gain on sale of Amplerissimo                   146,647    
Director [Member] | Stock Purchase Agreement [Member]                        
Purchase of treasury stock from officer         $ 60,000   $ 69,612 $ 94,495    
Purchase of treasury stock, shares         20,000   15,000 20,000      
Employee [Member] | Potentially dilutive securities [Member] | On January 1, 2018 [Member]                        
Stock options granted                   25,000    
Exercise period                   4 years    
Exercise price                   $ 1.00    
Stock options vested                   25,000